Data Tables for study from Sulforaphane Bioavailability and Chemopreventive Activity in Women Scheduled for Breast Biopsy
Year: 2023
Type: other
Abstract: Supplementary Table 1. Basic characteristics of women in the study Supplementary Table 2. Incidence of reported grade 2 adverse events in the BroccoMax{trade mark, serif} trial (treatment-related) Supplementary Table 3. Sulforaphane (SFN) and SFN metabolite levels in urine and plasma as well as histone deacetylase (HDAC) activity changes from pre- to post-treatment by treatment group Supplementary Table 4. Log2-transformed LSMEANS of immunohistochemistry H-score of selected breast tissue biomarkers in women scheduled for breast biopsy participating the BroccoMax{trade mark, serif} trial
Authors: Lauren L. Atwell, Zhenzhen Zhang, Motomi Mori, Paige E. Farris, John T. Vetto, Arpana M. Naik, Karen Y. Oh, Philippe Thuillier, Emily Ho, Jackilen Shannon
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362636075